News

  • February 15, 2017

    Nemaura Medical Inc., to present sugarBEAT® Poster at the Advanced Technologies and Treatments for Diabetes Symposium (ATTD) in Paris, February 16th 2017

    15th February 2017, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD), (“Nemaura”), a medical device company developing a non-invasive,...

    September 2, 2016

    Nemaura Medical Inc., sign Letter of Intent with Shenzen CAS Health Corp, for potential JV and manufacture of their sugarBEAT® system

    2nd September 2016, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura” or  the “Company”), a medical device company developing...

    August 4, 2016

    Nemaura Medical Inc., completes second FDA Pre-submission meeting and appoints Navigant to submit IDE for Nemaura’s sugarBEAT® system

      4th August 2016, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally...

    April 15, 2016

    Interim Clinical Data on Increased Measurement Frequency for sugarBEAT® CGM Released by Nemaura Medical

      14th April 2016, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally...

    March 15, 2016

    Nemaura Medical Announces receipt of notification of CE Approval for its sugarBEAT® Continuous Glucose Monitoring System

    March 15th, 2016, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally invasive...

    December 2, 2015

    Nemaura Medical Announces Joint Venture for European Launch of sugarBEAT® System

    December 2, 2015, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally invasive...

    October 13, 2015

    Nemaura Medical Announces Filing of Application for FDA Pre-Submission Program for sugarBEAT® System

    13th October 2015, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally invasive...

    October 5, 2015

    Nemaura Medical Present Positive Interim Clinical Trial Results of its sugarBEAT® System

    5th October 2015, Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing the sugarBEAT® CGM System as...

    May 1, 2015

    Nemaura Medical to Present Positive Interim Clinical Trial Results of its sugarBEAT® System at the Marcum Microcap Conference, New York

    Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing the sugarBEAT® CGM System as a non-invasive, wireless...

    May 1, 2015

    Nemaura Medical to Present at the 2015 Marcum Microcap Conference

    Nemaura Medical Inc. (OTC BB: NMRD), a leading developer of minimally-invasive transdermal diagnostic technologies, announced today that Dr. D...